BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25264974)

  • 1. E-health to manage distress in patients with an implantable cardioverter-defibrillator: primary results of the WEBCARE trial.
    Habibović M; Denollet J; Cuijpers P; Spek VR; van den Broek KC; Warmerdam L; van der Voort PH; Herrman JP; Bouwels L; Valk SS; Alings M; Theuns DA; Pedersen SS
    Psychosom Med; 2014 Oct; 76(8):593-602. PubMed ID: 25264974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients.
    Sears SF; Sowell LD; Kuhl EA; Kovacs AH; Serber ER; Handberg E; Kneipp SM; Zineh I; Conti JB
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):858-64. PubMed ID: 17584267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life.
    Pedersen SS; Spek V; Theuns DA; Alings M; van der Voort P; Jordaens L; Cuijpers P; Denollet J; van den Broek KC
    Trials; 2009 Dec; 10():120. PubMed ID: 20030843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
    Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
    J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Web-based distress management for implantable cardioverter defibrillator patients: A randomized controlled trial.
    Habibović M; Denollet J; Cuijpers P; van der Voort PH; Herrman JP; Bouwels L; Valk SD; Alings M; Theuns DA; Pedersen SS
    Health Psychol; 2017 Apr; 36(4):392-401. PubMed ID: 28192003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in psychological distress and quality of life in patients with an ICD 1-year postimplant.
    Starrenburg A; Pedersen S; van den Broek K; Kraaier K; Scholten M; Van der Palen J
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):843-52. PubMed ID: 24697703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attrition and adherence in a WEB-Based Distress Management Program for Implantable Cardioverter defibrillator Patients (WEBCARE): randomized controlled trial.
    Habibović M; Cuijpers P; Alings M; van der Voort P; Theuns D; Bouwels L; Herrman JP; Valk S; Pedersen S
    J Med Internet Res; 2014 Feb; 16(2):e52. PubMed ID: 24583632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring treatment expectations in patients with an implantable cardioverter-defibrillator using the EXPECT-ICD scale.
    Habibović M; Pedersen SS; van den Broek KC; Denollet J
    Europace; 2014 Jul; 16(7):1022-7. PubMed ID: 24596397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in anxiety and concerns about the cardioverter defibrillator.
    Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
    Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator.
    Crössmann A; Schulz SM; Kühlkamp V; Ritter O; Neuser H; Schumacher B; Bauer W; Pauli P
    Psychosom Med; 2010 Jun; 72(5):434-41. PubMed ID: 20410252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female-specific education, management, and lifestyle enhancement for implantable cardioverter defibrillator patients: the FEMALE-ICD study.
    Vazquez LD; Conti JB; Sears SF
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1131-40. PubMed ID: 20487354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimism as predictor of patient-reported outcomes in patients with an implantable cardioverter defibrillator (data from the WEBCARE study).
    Habibović M; Broers E; Heumen D; Widdershoven J; Pedersen SS; Denollet J
    Gen Hosp Psychiatry; 2018; 50():90-95. PubMed ID: 29127812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
    Ingles J; Sarina T; Kasparian N; Semsarian C
    Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions.
    Lewin RJ; Coulton S; Frizelle DJ; Kaye G; Cox H
    Heart; 2009 Jan; 95(1):63-9. PubMed ID: 18070951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
    Udlis KA
    J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
    Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological implications of ICD implantation in a New Zealand population.
    Newall EG; Lever NA; Prasad S; Hornabrook C; Larsen PD
    Europace; 2007 Jan; 9(1):20-4. PubMed ID: 17224417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program.
    Kuhl EA; Sears SF; Vazquez LD; Conti JB
    J Cardiovasc Nurs; 2009; 24(3):225-31. PubMed ID: 19390340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator.
    Hoogwegt MT; Kupper N; Jordaens L; Pedersen SS; Theuns DA
    Europace; 2013 Oct; 15(10):1468-74. PubMed ID: 23608028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator.
    Hoogwegt MT; Kupper N; Theuns DA; Jordaens L; Pedersen SS
    Europace; 2012 Jan; 14(1):74-80. PubMed ID: 21920910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.